Bonne nouvelle pour Axela!

Axela Biosensors was recognized as one of “Canada’s Top 10 Life Science Company’s”. There is a press release that was sent out to the national wire by OLSC.

OTTAWA, Ontario, November 7, 2005 – The Ottawa Life Sciences Council (OLSC) is pleased to announce this year’s finalists in the Canada’s Top 10 Life Science Companies Competition (Canada’s Top 10). The 2005/2006 finalists will present their company to an audience of venture capitalists, potential strategic alliance partners and conference delegates at BioNorth 2005, one of North America’s premier life science conferences.

Canada’s Top 10 finalists are selected from a pool of entrants by an independent international jury of life science venture capitalists. Entrant companies were classified as either early stage (seeking first and second round financing) or emerging and late stage (seeking mezzanine or later stage financing) opportunities. Based on their expert knowledge of investment in the life sciences sector, the jury selected the companies that they felt offered the best investment and partnership prospects.

2005/2006 Finalists:
- Early Stage • Axela Biosensors Inc. (Toronto, ON) • iCo Therapeutics Inc. (Vancouver, BC) • Innodia Inc. (Laval, QC) • Trillium Therapeutics Inc. (Toronto, ON) • Variation Biotechnologies Inc. (Ottawa, ON / Gatineau, QC)
- Emerging and Late Stage • Allon Therapeutics Inc. (Vancouver, BC) • Bioaxone Thérapeutique Inc. (St. Laurent, QC) • Inimex Pharmaceuticals (Vancouver, BC) • YM Biosciences Inc. (Mississauga, ON) • Zelos Therapeutics Inc. (Ottawa, ON)